Pharmaceutical manufacturers and distributors increasingly are being called for duty in the nationwide war on drugs, particularly in covert operations where the government believes those in the corporate supply chain have crept over enemy lines. <\/p>\n
In the midst of one of the worst drug abuse crises in American history, the Department of Justice has the responsibility to ensure that our drug laws are being enforced, Attorney General Jeff Sessions said in a statement. Part of that mission is holding drug manufacturers accountable for their actions. <\/p>\n
In a first-of-its-kind case that highlights the governments broadening enforcement stance to conquer the nationwide opioid epidemic, Mallinckrodt Pharmaceuticalsa maker of generic oxycodoneon July 11 reached a $35 million settlement with the government to resolve allegations that the pharmaceutical manufacturer failed to report suspicious orders of pharmaceutical drugs, and for record-keeping violations. <\/p>\n
... To get the full story, subscribe now. <\/p>\n
Single-user subscription, one year | $1,199 <\/p>\n
For multi-user subscriptions, email or call (888) 519-9200. <\/p>\n
<\/p>\n
View post: <\/p>\n
The compliance side of the war on drugs - Compliance Week (subscription)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Pharmaceutical manufacturers and distributors increasingly are being called for duty in the nationwide war on drugs, particularly in covert operations where the government believes those in the corporate supply chain have crept over enemy lines. Continue reading